Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Placebo Controlled, Two-Arms, Multicenter, Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).

NCT06736288 is registered in ClinicalTrials.gov with Laboratorio Farmaceutico SIT srl as lead sponsor.

NCT NCT06736288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06736288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Placebo Controlled, Two-Arms, Multicenter, Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).
Lead sponsor
Laboratorio Farmaceutico SIT srl
Phase
Phase 4
Overall status
Recruiting
Start date
October 21, 2025
Completion date
April 30, 2029
Enrollment
240 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection (lrti), respiratory infection